Peter D. O'Hanley

2007

In 2007, Peter D. O'Hanley earned a total compensation of $616.2K as SVP of Clinical Development and Regulatory Affairs at Sarepta Therapeutics, a 13% increase compared to previous year.

Compensation breakdown

Bonus$42,000
Option Awards$305,228
Salary$260,000
Other$9,000
Total$616,228

O'Hanley received $305.2K in option awards, accounting for 50% of the total pay in 2007.

O'Hanley also received $42K in bonus, $260K in salary and $9K in other compensation.

Rankings

In 2007, Peter D. O'Hanley's compensation ranked 5,446th out of 8,700 executives tracked by ExecPay. In other words, O'Hanley earned more than 37.4% of executives.

ClassificationRankingPercentile
All
5,446
out of 8,700
37th
Division
Manufacturing
2,037
out of 3,314
39th
Major group
Chemicals And Allied Products
445
out of 746
40th
Industry group
Drugs
296
out of 546
46th
Industry
Pharmaceutical Preparations
214
out of 364
41st
Source: SEC filing on April 14, 2009.

O'Hanley's colleagues

We found five more compensation records of executives who worked with Peter D. O'Hanley at Sarepta Therapeutics in 2007.

2007

Alan Timmins

Sarepta Therapeutics

Chief Operating Officer

2007

K Forrest

Sarepta Therapeutics

Chief Executive Officer

2007

Patrick Iversen

Sarepta Therapeutics

Senior Vice President of Strategic Alliances

2007

Dwight Weller

Sarepta Therapeutics

Senior Vice President of Chemistry and Manufacturing

2007

Mark Webber

Sarepta Therapeutics

Chief Financial Officer

You may also like